Structural Formula (597aac65 2fa1 481f 8e40 D3500036480b 01)
Buspirone Hydrochloride Tablet
Product Images NDC 71335-2237
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Buspirone Hydrochloride (NDC 71335-2237). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Bryant Ranch Prepack, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Figure (597aac65 2fa1 481f 8e40 D3500036480b 02)
This text provides instructions on how to take different dosages of a medication based on the prescribed tablet strength. It specifies the dosage for a 15 mg tablet and a 30 mg tablet. The text includes information on how to split the tablets to take different dosage amounts, such as two-thirds, one-third, or one-half of a tablet. The text might not be readable and is not available.*
Figure (597aac65 2fa1 481f 8e40 D3500036480b 03)
Label (Lbl713352237)
This is a description for busPIRone Hydrochloride Tablets. Each tablet contains 7.5 mg of Buspirone Hydrochloride. It is important to keep this medication out of reach of children and store it at a temperature between 20° to 25°C (68° to 77°F). The tablets should be dispensed in a tight, light-resistant container with a child-resistant closure. This medication is manufactured by Cadila Healthcare Ltd. and repackaged by Bryant Ranch Prepack, Inc. in Burbank, CA. Please note that the rest of the text is not readable.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
